SEARCH RESULTS FOR: "Tag: ABBV"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2022(1)
2021(4)
2020(3)
2019(6)
2018(10)
2017(4)
2016(2)
2015(4)
2014(5)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(1)
Analyst Update(3)
Analyst Upgrades(1)
Bernie's Content(1)
Buzz Stocks(9)
By the Numbers(1)
Earnings Preview(1)
Editor's Pick(1)
Expectational Analysis(1)
General(6)
Indicator of the Week(1)
Intraday Option Activity(1)
Midday Market Check(2)
Opening View(4)
Quantitative Analysis(1)
Stocks On the Move(6)
Technical Analysis(2)
Trade Postmortem(1)
Unusual Trading Activity(1)

1/7/2022 10:23 AM
As we say welcome in the New Year with cautious optimism, it’s important to note not just the best stock picks to bet on, but also the ones to avoid. Historically, there are a notable amount of names ...
10/12/2021 3:04 PM
Last month was a doozy for investors. We've discussed how investors can manage September seasonality ad nauseam, but what about the other side of the coin? What stocks out there could fall victim to ...
10/1/2021 3:01 PM
If you're an investor, you're probably sick of the words 'September seasonality' by now. As the historically bearish period came to a close and ushered in a new month, all eyes were on Congress and ...
9/29/2021 10:02 AM
The U.S. Food and Drug Administration (FDA) just approved AbbVie Inc's (NYSE:ABBV) migraine prevention treatment, marking the company's third drug in its roster for severe headaches. The once-daily o...
3/16/2021 10:19 AM
AbbVie Inc (NYSE:ABBV) is in the spotlight this morning, after news that the pharmaceutical company is in talks to sell a $5 billion portfolio of women's drugs. According to Reuters, the company acqui...
 
Special Offers from Schaeffer's Trading Partners